Mr. Daniel Pelak
Daniel A. Pelak has served as Lead Director of the Board since October 2017 and is also Chairman of the Compliance Committee and a member of our Nominating and Corporate Governance Committee and our Compensation Committee. Previously, Mr. Pelak had served as Chairman of the Board since 2010. Mr. Pelak has over 30 years of experience as a senior executive in the medical technology industry. He has served as an operating partner with WCAS focusing on healthcare investments since November 2008. He was previously the Chief Executive Officer of Inner Pulse, a privately held medical device company, from September 2005 to July 2008. Before joining InnerPulse, he was the Chief Executive Officer of Closure Medical Corporation, a publicly traded global leader in the development and manufacture of biomaterial-based medical adhesives, from 2002 until its acquisition by Johnson & Johnson in 2005. He began his industry career at Medtronic, Inc., where his executive assignments included Vice President of U.S. Marketing, and later in his career, worldwide responsibility for three different operating divisions as the Vice President and General Manager. Mr. Pelak currently serves on the board of directors of Vertos Medical, Inc. and served on the board of directors of the Spectranetics Corporation until its acquisition by Royal Phillips in August 2017. Mr. Pelak holds a B.S. from the Pennsylvania State University. Mr. Pelak was selected to serve as a director because of his experience as an executive in the healthcare industry and his many years of experience with both public and private company board of directors.